Announcing CancerKB 4.0
✅ NCCN & FDA-approved therapies for blood cancers.
✅ Harmonized diagnostic & prognostic interpretations
✅ Expanded content: added 150 biomarkers, over 1,000 curated genes, and 65,000 clinical trials.
#CancerGenomics #CancerKB
www.goldenhelix.com/resources/we...
✅ NCCN & FDA-approved therapies for blood cancers.
✅ Harmonized diagnostic & prognostic interpretations
✅ Expanded content: added 150 biomarkers, over 1,000 curated genes, and 65,000 clinical trials.
#CancerGenomics #CancerKB
www.goldenhelix.com/resources/we...
The Latest and Greatest Golden Helix CancerKB 4.0 and Somatic Analysis within VSClinical
Discover how Golden Helix CancerKB 4.0 and VSClinical streamline the analysis of somatic mutations, integrating the latest NCCN and WHO updates for hematological cancers.
www.goldenhelix.com
December 24, 2024 at 6:23 PM
Announcing CancerKB 4.0
✅ NCCN & FDA-approved therapies for blood cancers.
✅ Harmonized diagnostic & prognostic interpretations
✅ Expanded content: added 150 biomarkers, over 1,000 curated genes, and 65,000 clinical trials.
#CancerGenomics #CancerKB
www.goldenhelix.com/resources/we...
✅ NCCN & FDA-approved therapies for blood cancers.
✅ Harmonized diagnostic & prognostic interpretations
✅ Expanded content: added 150 biomarkers, over 1,000 curated genes, and 65,000 clinical trials.
#CancerGenomics #CancerKB
www.goldenhelix.com/resources/we...